CCT367766 is primarily utilized in cancer research, particularly in the study of targeted therapies. It functions as a potent inhibitor of specific kinases involved in tumor growth and proliferation. Researchers employ this compound to investigate its efficacy in disrupting signaling pathways that contribute to cancer progression. Its application extends to preclinical studies, where it is tested for its potential to enhance the effectiveness of existing treatments or to serve as a standalone therapeutic agent. Additionally, CCT367766 is used in molecular biology to better understand the mechanisms of kinase-related diseases and to identify novel drug targets.